The Complete Jordan Medical Device Registration Pathway: From Classification to Certificate

1. Key takeaways

Medical device registration in Jordan is a six-node chain: determine the product classification → appoint an authorised representative (AR) → apply for an electronic appointment through the Cosmo system and pay the required fees → complete the application form and submit the full set of documents → technical review (which may include local sample submission) → obtain the registration certificate. Because each node depends on the completion of the one before it, a delay at any single node propagates through the whole schedule. GRZAN’s conclusion is that nearly all of the time lost along this chain occurs at the third and fifth nodes, not during dossier preparation.

• The second conclusion: foreign manufacturers have no direct right of access. The first action is not preparing documents but appointing the AR — because the application account in the JFDA system, the appointment request, the submission of original documents, subsequent deficiency responses and vigilance reporting are all completed with the AR as the responsible party.
• The third conclusion: from 9 October 2025 onwards, Class IIb devices may not be imported until registration has been completed and approved by JFDA (implantable devices are exempt). This change turns registration from a “pre-market procedure” into a “customs clearance precondition”, and it directly rewrites project scheduling logic.

2. Legal basis

Article numbers are subject to the Arabic originals published in the official gazette of Jordan and issued by JFDA.

3. Expert insights

Insight 1: the classification determination is the pricing mechanism of the entire chain. The classification determines the depth of the dossier, whether a clinical evaluation report is required, whether local sample submission is possible, and whether the product falls within the mandatory precondition scope of the 2025 circular. GRZAN recommends that companies complete the classification determination before commercial negotiations begin, because it directly determines the quotation and the delivery commitments a company can make. In other words, the classification does not merely fix the risk tier under which the product will be reviewed; it shapes the entire project envelope, since the dossier contents, the possible testing burden and the applicable import conditions all follow from it.

Insight 2: the Cosmo appointment is a procedural gate unique to Jordan. The applicant must upload the application form in the JFDA Cosmo system and electronically attach the required documents in order to obtain an appointment slot; JFDA then notifies the attendance date by SMS. On the appointment day, the merchant or the authorised agent must deliver the original documents in person to the Medical Devices and Medical Supplies Directorate. This hybrid model of “electronic appointment plus on-site submission” is the step that Chinese manufacturers most easily underestimate in terms of time cost. The appointment slot, the SMS notification and the on-site delivery are three separate actions, and none of them can be compressed into the others; treating them as a single administrative step is a common source of lost weeks.

Insight 3: fees are paid before submission. The applicant should pay the required fees first, and only then complete the application form and submit all documents. Where the fees have not been settled in full, no valid acceptance of the application can arise.

Insight 4: the objection window is a built-in remedy. The applicant has the right to file an objection within 30 working days of being notified of a relevant decision of the devices committee, and the corresponding fee is 100 JOD. When an unfavourable decision is received, companies should first assess the feasibility of an objection before deciding whether to restart the application.

4. Practical recommendations

• Make the appointment of the AR step zero of the project. The commercial registration scope of the AR must cover medical device or medical consumables import activities, and the account it opens in the JFDA system must be able to link a qualifying warehouse. Without the AR, none of the subsequent nodes can even be opened: the appointment account and the warehouse link are prerequisites for the Cosmo step.
• Build the project plan backwards from the six nodes. Using practical estimates of the cycle: Class I approximately 4 months, Class IIa approximately 4 months, Class IIb approximately 4 to 8 months, Class III approximately 8 months; if local sample submission is triggered, the cycle extends further. These ranges should be treated as planning values and re-checked as the project progresses.
• Re-plan import arrangements for Class IIb products. After the 2025 circular took effect, Class IIb products without a registration certificate cannot complete import; the entry arrangements for samples, clinical trial units and exhibition items all need to be redesigned. Shipping goods before the certificate is in hand would convert the registration delay directly into a customs problem.

5. Verification checklist

• □ Complete the product classification determination and document the rationale in writing
• □ Confirm the AR has been appointed and its commercial registration covers device or consumables import
• □ Confirm the AR has opened an account in the JFDA system and linked a compliant warehouse
• □ Complete the appointment application in the Cosmo system and confirm the attendance date notified by SMS
• □ Confirm the fees have been paid in full before submission
• □ Check whether Class IIb products fall within the prior-registration requirement of Circular No. 54863/1/5
• □ Record the objection window (30 working days) and the fee (100 JOD)
• □ Verify the cited article numbers against the Arabic original of the official gazette
• □ Regulatory information verified as of 29 October 2026

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Jordanian market. Our team manages JFDA registration applications, prepares reference-approval dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzan.com